A New CRISPR-Engineered Cancer Model to Test Therapeutics

News   Oct 06, 2017 | Original story from Broad Institute

 
A New CRISPR-Engineered Cancer Model to Test Therapeutics

Credit : Susanna M. Hamilton, Broad Communications

 
 
 

RELATED ARTICLES

The Protein Lasso Implicated in Breast Cancer

News

Certain types of RNA are implicated in the production of pro-breast cancer proteins. Now, a new study has shed light on the mechanism by which these RNAs manipulate DNA to produce these proteins.

READ MORE

New Target for Immunotherapy for Solid Tumors?

News

Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

READ MORE

DNA Barcodes Help Track Cells

News

Each of our genomes contains millions of one-letter variations called single nucleotide polymorphisms. Researchers have now developed a technique that utilizes these unique features to track cells from different donors.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE